FIELD: chemistry; medicine; pharmacology.
SUBSTANCE: invention refers to biochemistry, medicine and pharmacology. Disclosed is the use of bis (μ-tartrate)di(μ-hydroxo)triethanolammonium germathanate (IV) of general formula
,
wherein Tart - tartaric acid residue -OC(O)CH(O-)CH(O-)C(O)O-, as a means of modulating mitochondrial bioenergetics animal liver cells.
EFFECT: invention widens range of adaptogenic agents.
1 cl, 1 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF BIS(Μ-TARTRATO)DI(Μ-HYDROXO)GERMANATE (IV) TRIETHANOLAMMONIUM FOR INHIBITING TOTAL ACTIVITY OF BASIC (ALKALINE) PHOSPHOLIPASE A2 OF MONONUCLEAR CELLS | 2020 |
|
RU2733166C1 |
| METHOD OF INHIBITING TOTAL ACTIVITY OF BASIC (ALKALINE) PHOSPHOLIPASE A2 OF MONONUCLEAR CELLS USING BIS(Μ-TARTRATO)DI(Μ-HYDROXO)GERMANATE (IV) TRIETHANOLAMMONIUM | 2020 |
|
RU2732880C1 |
| USE OF 1-(GERMATRAN-1-YL)-1-HYDROXYETHYLAMINE FOR INHIBITING THE DEVELOPMENT OF ATHEROSCLEROSIS IN THE EXPERIMENT | 2020 |
|
RU2746321C1 |
| METHOD OF ATHEROGENESIS CORRECTION IN EXPERIMENT USING 1-(GERMATRAN-1-YL)-1-OXYETHYLAMINE | 2020 |
|
RU2741906C1 |
| BIS(µ-TARTRATO)DI(µ-HYDROXO)GERMANATE(IV) TRIETHANOLAMMONIUM INCREASING THE STATIC AND DYNAMIC PERFORMANCE | 2016 |
|
RU2661616C2 |
| USE OF 1-(HERMATRANE-1-YL)-1-OXYETHYLAMINE FOR INHIBITING TOTAL ACTIVITY OF BASIC (ALKALINE) PHOSPHOLIPASE A2 OF MONONUCLEAR CELLS | 2020 |
|
RU2732883C1 |
| METHOD FOR SUPPRESSING TOTAL ACTIVITY OF BASIC (ALKALINE) PHOSPHOLIPASE A2 OF MONONUCLEAR CELLS USING 1-(HERMATRANE-1-YL)-1-OXYETHYLAMINE | 2020 |
|
RU2732881C1 |
| METHOD OF PRODUCING CELL RESPIRATION STIMULATING SUBSTANCES | 2011 |
|
RU2472775C1 |
| METHOD OF DECREASE OF TOXICITY OF MEDICINAL AGENTS, METALS, ORGANIC AND INORGANIC COMPOUNDS AND OTHER TOXINS | 1997 |
|
RU2104033C1 |
| NATURAL PHOSPHOLIPID AGENT | 2008 |
|
RU2367443C1 |
